Clinical trial Recruiting at 1 site Observational Ages 18 and up

Night-to-night variability of physiological markers in home sleep apnea testing

Official title: Night-to-Night Variability of Novel Physiological Parameters in Home Sleep Apnea Testing

Run by Insel Gruppe AG, University Hospital Bern · NCT07555119 · Data updated 2026-11-12

This study tests how stable both traditional and novel sleep apnea markers are from one night to the next in people undergoing home sleep apnea testing.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment192 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern)
StatusRecruiting
StartedJuly 24, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJuly 29, 2026
Trial IDNCT07555119 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with suspected or diagnosed sleep-disordered breathing who are not on sleep therapies and can complete home sleep testing in German-speaking settings.

Probably not a fit

Patients who are unable to complete reliable sleep measurements or who have conditions excluding participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes night-to-night variability of traditional and newer physiological metrics collected during home sleep apnea testing. It aims to identify reliable markers that consistently reflect the impact of sleep apnea on the body, beyond the apnea-hypopnea index. Metrics under consideration include hypoxic burden, ventilatory burden, heart rate variability, autonomic arousals, and the pulse wave amplitude drop index. Findings could inform diagnostic practices and risk stratification for cardiovascular outcomes. The study is conducted at Inselspital and University of Bern in Switzerland with adult participants who meet the German guidelines for home sleep testing and have not used sleep therapies recently.

Why it matters

Potential benefit: If successful, the study could identify stable biomarkers to improve diagnostic accuracy and cardiovascular risk prediction in sleep apnea.

How similar studies have gone: Previous work suggests that novel metrics may better reflect cardiovascular risk, but their night-to-night stability requires confirmation in home testing settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with suspected or diagnosed sleep-disordered breathing, irrespective of disease severity, as defined by the indications for home sleep apnea testing in the German guidelines \[15\]
* No active treatment during sleep recordings or within preceding two weeks (e.g., mandibular advancement devices, positive airway pressure therapy)
* Written informed consent obtained

Exclusion Criteria:

* Age \<18 years
* Known or suspected neurological sleep disorder (e.g., narcolepsy, parasomnia)
* Known or suspected psychiatric sleep disorder
* Known or suspected central and complex sleep apnea
* Participants who are unable to perform sleep measurements reliably
* Insufficient knowledge of the project language (German)
* Inability to give consent
* Shift workers (with shift work \<2 weeks before testing)

Where it's running

  • Inselspital University Hospital and University Bern
    Bern, Switzerland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.